Hexyl-aminolevulinate-mediated photodynamic therapy: How to spare normal urothelium. An in vitro approach

Lasers in Surgery and Medicine

Volumn 39, Issue 1, 2007, Pages 67-75

  Vaucher, Laurent ^a,b   Jichlinski, Patrice ^b   Lange, Norbert ^a   Ritter Schenk, Céline ^a   Van Den Bergh, Hubert ^c   Kucera, Pavel ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c EPFL   (Switzerland)

Author keywords

In vitro; Irradiation threshold, dosimetry; Photodynamic lesions; Urothelium

Indexed keywords

AMINOLEVULINIC ACID HEXYL ESTER; GREEN FLUORESCENT PROTEIN; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN; REACTIVE OXYGEN METABOLITE; RHODAMINE 123;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CANCER; BLEACHING; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; DOSIMETRY; IN VITRO STUDY; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REACTION OPTIMIZATION; SCANNING ELECTROCHEMICAL MICROSCOPY; UROTHELIUM;

AMINOLEVULINIC ACID; ANIMALS; CELL SURVIVAL; MICROSCOPY, ELECTRON, SCANNING; MUCOUS MEMBRANE; PHOTOBLEACHING; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; REACTIVE OXYGEN SPECIES; SOFT TISSUE INJURIES; SPECTROMETRY, FLUORESCENCE; SWINE; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 33846921989     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.20416     Document Type: Article

References (35)

1. Brown SB, Brown EA, Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol 2004;5(8):497-508.
2. Michels S, Schmidt-Erfurth U. Photodynamic therapy with verteporfin: A new treatment in ophthalmology. Semin Ophthalmol 2001;16(4):201-206.
3. Solban N, Ortel B, Pogue B, Hasan T. Targeted optical imaging and photodynamic therapy. Ernst Schering Res Found Workshop 2005;49:229-258.
4. Jichlinski P, Leisinger HJ. Photodynamic therapy in superficial bladder cancer: Past, present and future. Urol Res 2001;29(6):396-405.
5. Jichlinski P, Guillou L, Karlsen SJ, Malmstrom PU, Jocham D, Brennhovd B, Johansson E, Gartner T, Lange N, van den Bergh H, Leisinger HJ. Hexyl aminolevulinate fluorescence cystoscopy: New diagnostic tool for photodiagnosis of superficial bladder cancer - A multicenter study. J Urol 2003;170(1):226-229.
6. Lange N, Jichlinski P, Zellweger M, Forrer M, Marti A, Guillou L, Kucera P, Wagnieres G, van den Bergh H. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: A pilot study. Br J Cancer 1999;80(1-2):185-193.
7. Jocham D, Witjes F, Wagner S, Zeylemaker B, van Moorselaar J, Grimm MO, Muschter R, Popken G, Konig F, Knuchel R, Kurth KH. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: A prospective, phase III multicenter study. J Urol 2005;174(3):862-866; discussion 866.
8. Kamuhabwa AA, Roskams T, D'Hallewin MA, Baert L, Van Poppel H, de Witte PA. Whole bladder wall photodynamic therapy of transitional cell carcinoma rat bladder tumors using intravesically administered hypericin. Int J Cancer 2003;107(3):460-467.
9. van den Bergh H. On the evolution of some endoscopic light delivery systems for photodynamic therapy. Endoscopy 1998;30(4):392-407.
10. Lange N, Vaucher L, Marti A, Etter AL, Gerber P, van Den Bergh H, Jichlinski P, Kucera P. Routine experimental system for defining conditions used in photodynamic therapy and fluorescence photodetection of (non-) neoplastic epithelia. J Biomed Opt 2001;6(2):151-159.
11. Marti A, Lange N, van den Bergh H, Sedmera D, Jichlinski P, Kucera P. Optimisation of the formation and distribution of protoporphyrin IX in the urothelium: An in vitro approach. J Urol 1999;162(2):546-552.
12. Emmendorffer A, Hecht M, Lohmann-Matthes ML, Roesler J. A fast and easy method to determine the production of reactive oxygen intermediates by human and murine phagocytes using dihydrorhodamine 123. J Immunol Methods 1990;131(2):269-275.
13. Gaforio JJ, Serrano MJ, Ortega E, Algarra I, Alvarez de Cienfuegos G. Use of SYTOX green dye in the flow cytometric analysis of bacterial phagocytosis. Cytometry 2002;48(2):93-96.
14. Marcinkowska A, Malarska A, Saczko J, Chwilkowska A, Wysocka T, Drag-Zalesinska M, Wysocka T, Banas T. Photofrin - Factor of photodynamic therapy induces apoptosis and necrosis. Folia Histochem Cytobiol 2001;39 Suppl 2:177-178.
15. Kuzelova K, Grebenova D, Pluskalova M, Marinov I, Hrkal Z. Early apoptotic features of K562 cell death induced by 5-aminolaevulinic acid-based photodynamic therapy. J Photochem Photobiol B 2004;73(1-2):67-78.
16. Luksiene Z, Eggen I, Moan J, Nesland JM, Peng Q. Evaluation of protoporphyrin IX production, phototoxicity and cell death pathway induced by hexylester of 5-aminolevulinic acid in Reh and HPB-ALL cells. Cancer Lett 2001;169(1):33-39.
17. Rotomskis R, Bagdonas S, Streckyte G. Spectroscopic studies of photobleaching and photoproduct formation of porphyrins used in tumour therapy. J Photochem Photobiol B 1996;33(1):61-67.
18. Bagdonas S, Ma LW, Iani V, Rotomskis R, Juzenas P, Moan J. Phototransformations of 5-aminolevulinic acid-induced protoporphyrin IX in vitro: A spectroscopic study. Photochem Photobiol 2000;72(2):186-192.
19. Robinson DJ, de Bruijn HS, van der Veen N, Stringer MR, Brown SB, Star WM. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: The effect of radiant exposure and irradiance and the resulting biological effect. Photochem Photobiol 1998;67(1):140-149.
20. Hua Z, Gibson SL, Foster TH, Hilf R. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo. Cancer Res 1995;55(8);1723-1731.
21. Veenhuizen RB, Stewart FA. The importance of fluence rate in photodynamic therapy: Is there a parallel with ionizing radiation dose-rate effects? Radiother Oncol 1995;37(2):131-135.
22. Gronlund-Pakkanen S, Pakkanen TM, Talja M, Kosma VM, Ala-Opas M, Alhava E. The morphological changes in rat bladder after photodynamic therapy with 5-aminolaevulinic acid-induced protoporphyrin IX. BJU Int 2000;86(1):126-132.
23. Van Staveren HJ, Beek JF, Verlaan CW, Edixhoven A, De Reijke TM, Brutel De La Rivi EG, Star WM. Comparison of normal piglet bladder damage after PDT with oral or intravesical administration of ALA. Lasers Med Sci 2002;17(4):238-245.
24. Kriegmair M, Waidelich R, Lumper W, Ehsan A, Baumgartner R, Hofstetter A. Integral photodynamic treatment of refractory superficial bladder cancer [see comments]. J Urol 1995;154(4):1339-1341.
25. Pinthus JH, Bogaard A, Weersiwk R, Wilson BC, Trachtenberg J. Photodynamic therapy for urological malignancies: Past to current approaches. J Urol 2006;175(4):1201-1207.
26. Robinson DJ, de Bruijn HS, van der Veen N, Stringer MR, Brown SB, Star WM. Protoporphyrin IX fluorescence photobleaching during ALA-mediated photodynamic therapy of UVB-induced tumors in hairless mouse skin. Photochem Photobiol 1999;69(1):61-70.
27. Glanzmann T, Forrer M, Blant SA, Woodtli A, Grosjean P, Braichotte D, van den Bergh H, Monnier P, Wagnieres G. Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model: Comparison with clinical measurements. J Photochem Photobiol B 2000;57(1):22-32.
28. Rhodes LE, Tsoukas MM, Anderson RR, Kollias N. Iontophoretic delivery of ALA provides a quantitative model for ALA pharmacokinetics and PpIX phototoxicity in human skin. J Invest Dermatol 1997;108(1):87-91.
29. Georgakoudi I, Foster TH. Singlet oxygen versus nonsinglet oxygen-mediated mechanisms of sensitizer photobleaching and their effects on photodynamic dosimetry. Photochem Photobiol 1998;67(6):612-625.
30. Moan J, Streckyte G, Bagdonas S, Bech O, Berg K. Photobleaching of protoporphyrin IX in cells incubated with 5-aminolevulinic acid. Int J Cancer 1997;70(1):90-97.
31. Mitra S, Finlay JC, McNeill D, Conover DL, Foster TH. Photochemical oxygen consumption, oxygen evolution and spectral changes during UVA irradiation of EMT6 spheroids. Photochem Photobiol 2001;73(6):703-708.
32. Coutier S, Mitra S, Bezdetnaya LN, Parache RM, Georgakoudi I, Foster TH, Guillemin F. Effects of fluence rate on cell survival and photobleaching in meta-tetra-(hydroxyphenyl)chlorin-photosensitized Colo 26 multicell tumor spheroids. Photochem Photobiol 2001;73(3):297-303.
33. El Khatib S, Didelon J, Leroux A, Bezdetnaya L, Notter D, D'Hallewin M. Kinetics, biodistribution and therapeutic efficacy of hexylester 5-aminolevulinate induced photodynamic therapy in an orthotopic rat bladder tumor model. J Urol 2004;172(5 Pt 1):2013-2017.
34. Martin OC, Pagano RE. Internalization and sorting of a fluorescent analogue of glucosylceramide to the Golgi apparatus of human skin fibroblasts: Utilization of endocytic and nonendocytic transport mechanisms. J Cell Biol 1994;125(4):769-781.
35. Castro DJ, Gaskin A, Saxton RE, Reisler E, Nishimura E, To SY, Rodgerson DO, Layfield LJ, Tartell PB, et al. Photodynamic therapy using rhodamine-123 as a new laser dye: Biodistribution, metabolism and histology in New Zealand rabbits. Laryngoscope 1991;101(2):158-164.